3D Bio Printing Market is Expected to Reach USD 1.3 billion by 2024

Posted on 2018-07-26 by Goldstein Research in Healthcare // 0 Comments

New York, USA, 2018-Jul-26 — /EPR Network/ —According to Goldstein Research, 3D bioprinting market is expected to reach USD 1.3 billion by 2024, growing at a CAGR of 13.8% over the forecast period 2016-2024. Rising need for human organs for transplants and growing applications in the pharmaceutical industry such as regenerative medicines and drug discovery among others is driving the growth of 3D bioprinting market. Global 3D bioprinting market segmentation has been carried out on the basis of technology and applications. Application segment is further bifurcated into pharmaceutical, tissue and organ regeneration, bones and 3D cell culture.

Global 3D bioprinting market is majorly driven by North America and Europe dominates the global 3D bioprinting market with approximately 60% market share. However, it is expected that Asia Pacific region is poised to take lead in 3D bioprinting technology in future. The Asia Pacific is the key region for the potential adoption of 3D bioprinting technology, dominated by South Korea, Japan, and China, which currently contributes to the 21.0% of the share in global 3D bioprinting market.

Download Exclusive Sample Report @ https://www.goldsteinresearch.com/request-sample/3d-bio-printing-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024

Market Segmentation

On the basis of our in-depth analysis, Global 3D Bio-Printing Market can be segmented as follows:

By Technology

inkjet-BasedBio Printing
Extrusion Based Bio Printing
Laser-Based Bio Printing

By Applications

Pharmaceuticals
Tissue and Organ Regeneration
Bones
3D Cell Culture
other

By Region

North America (US, Canada) {Market Share (%), Market Size (USD Billion, Adoption Rate (%)}
Europe (UK, France, Italy, Germany, Spain, Hungary, Sweden, Russia, Poland and Rest of Europe) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
The Middle East and Africa (GCC Countries, North Africa, South Africa and Rest of the Middle East & Africa) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Latin America (Brazil, Mexico and Rest of Latin America) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Asia Pacific (China, Japan, India, Singapore, South Korea, Australia, New Zealand and Rest of Asia-Pacific) {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}
Rest of the World {Market Share (%), Market Size (USD Billion), Adoption Rate (%)}

Browse full Report@ https://www.goldsteinresearch.com/report/3d-bio-printing-market-outlook-2024-global-opportunity-and-demand-analysis-market-forecast-2016-2024

“Global 3D Bio-Printing Market Outlook 2024” contains a detailed overview of the global 3D bioprinting market. On the basis of our in-depth analysis, the market can be segmented in terms of market segmentation by technology and applications.

Further, for the in-depth analysis, Global 3D Bio-Printing Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This global market research report also includes competitive outlook of some of the major players profiling of companies such as Organao, BioBots, Cellink, Poietis, EnvisionTec Gmbh, Nano3D Biosciences Inc., Cyfuse Biomedical, etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services, and industries catered, financial analysis of the company and recent developments.

Overall, the report represents the global 3D bioprinting market trends along with a market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market-centric strategies according to the ongoing and expected trends in the future.

About Goldstein Research

Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.

Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear-cut forecasts. Our market research reports provide in-depth analysis of global and regional variations along with competitors’ overview. Our analysts working on healthcare market research reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in the rigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable for our clients’ needs and business agenda.

Market Segmentation

By Technology

By Applications

By Region

Matched content

Editor’s pick